In order to move closer to achieving the goals of precision medicine and individualized cancer care, participation in biobanking from large numbers of individuals representing all ethnicities is essential. The scarcity of tissues available at existing biobanks from racial and ethnic minorities poses a substantial constraint to conducting research needed to understand the biological basis of health disparities. Because cancer- causing genetic alterations vary across individuals and ethnicities, the practice of precision medicine requires knowledge acquired through the study of tumor tissue derived from individuals representing diverse populations. It is important to recognize that Hispanic/Latino (H/L) ethnicity is an admixture of European, African, and Amerindians ancestral genomes, the proportions of which vary widely across individuals from different geographical regions. Also, there are differences in cancer trends associated to cancer biology and admixture genetics among different H/L sub-populations. Despite being a large proportion of the ethnic minorities living in the US, to date, there has been no comprehensive availability of tumor tissue from H/L cancer patients in national biobanks. To address this disparity, we propose to continue to develop the existing research infrastructure of the Puerto Rico Biobank (PRBB) to support research initiatives designed to understand the biological basis of cancer health disparities. The purpose of the PRBB is to facilitate the optimal collection, processing, storage, and distribution of well-annotated human biospecimens derived from the island?s H/L population for use in investigator-initiated translational cancer research. Throughout the past 10 years, a solid infrastructure has been put in place to develop this unique biorepository in Puerto Rico. Through this resource, fresh frozen tissues, paraffin blocks, high-quality tumor-derived RNA, genomic DNA, and clinical and risk factor information are available to support research at both institutions focusing on molecular aspects and determinants of cancer health disparities involving H/L living in Florida and Puerto Rico. We propose to expand the existing Partnership?s biobank via three Specific Aims.
In Aim 1 we propose to continue the collection, processing, storage, and distribution of biospecimens in collaboration with local hospitals and clinics. In cooperation with the Partnership?s Outreach Core, efforts to consent healthy individuals during community outreach educational activities will continue.
In Aim 2, we propose to extend the documentation of demographic, clinical, pathological, and molecular data (?omic?, ancestry, next-gen sequence data) in collaboration with the Quantitative Sciences Core.
In Aim 3, we propose to foster new collaborative research projects focused on cancer research. As facilitator of translational research, the PRBB is placed at the forefront of the Precision Medicine initiative programmatic goals of improving disease risk prediction and developing diagnosis and treatment strategies based on individual differences in genes, lifestyle, and environment, focusing on a population that is under-represented in biobanks and research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA163068-09
Application #
10007774
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2012-09-24
Project End
2022-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
9
Fiscal Year
2020
Total Cost
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Jusino, Shirley; Fernández-Padín, Fabiola M; Saavedra, Harold I (2018) Centrosome aberrations and chromosome instability contribute to tumorigenesis and intra-tumor heterogeneity. J Cancer Metastasis Treat 4:
King, Jamie L; Zhang, Baotong; Li, Yixiang et al. (2018) TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer. Oncogenesis 7:69
Bonilla-Valentín, Fernando Javier; Cerra, Javier; Cáceres-Perkins, William et al. (2018) Case Report of IgM Multiple Myeloma: Diagnosing a Rare Hematologic Entity. Cancer Control 25:1073274817744448
Pérez-Morales, Jaileene; Núñez-Marrero, Angel; Santiago-Cardona, Pedro G (2018) Immunohistochemical Detection of Retinoblastoma Protein Phosphorylation in Human Tumor Samples. Methods Mol Biol 1726:77-84
Dutil, Julie; Godoy, Lenin; Rivera-Lugo, Rafael et al. (2018) No Evidence for the Pathogenicity of the BRCA2 c.6937?+?594T>G Deep Intronic Variant: A Case-Control Analysis. Genet Test Mol Biomarkers 22:85-89
Reverón, Dayana; López, Christian; Gutiérrez, Sylvia et al. (2018) Frequency of Mismatch Repair Protein Deficiency in a Puerto Rican Population with Colonic Adenoma and Adenocarcinoma. Cancer Genomics Proteomics 15:265-271
Gonçalves, Vânia; Hudson, Janella; Canavarro, Maria Cristina et al. (2018) Childbearing across borders: Fertility and parenthood attitudes and decisions among breast cancer survivors in USA and Portugal. Breast 40:16-22
Colón-Caraballo, Mariano; Torres-Reverón, Annelyn; Soto-Vargas, John Lee et al. (2018) Effects of histone methyltransferase inhibition in endometriosis. Biol Reprod 99:293-307
Rodríguez-López, Joshua L; Toro-Bahamonde, Alia M; Santiago-Méndez, Roberto J et al. (2018) An Unusual Case of Colorectal Adenocarcinoma Presenting as an Anterior Mediastinal Mass. Clin Colorectal Cancer 17:e115-e119
Lee, Miyoung; Gudas, Lorraine J; Saavedra, Harold I (2018) Detection of E2F-DNA Complexes Using Chromatin Immunoprecipitation Assays. Methods Mol Biol 1726:143-151

Showing the most recent 10 out of 72 publications